Nuzenio

Aldeyra Therapeutics

Aldeyra Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 8 publisher sources 100/100 entity strength

Latest news

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 06:56:07 GMT Aldeyra Therapeutics Inc (ALDX) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 16:36:05 GMT Aldeyra Therapeutics Inc (ALDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 14:27:03 GMT Aldeyra Therapeutics (NASDAQ:ALDX) Announces Quarterly Earnings Results - MarketBeatMarketBeat · Fri, 07 Aug 2026 02:14:15 GMT Aldeyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:37:49 GMT Aldeyra Therapeutics, Inc. Q2 2026: Net loss $5.45M, EPS $(0.09) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMT Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutic - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 08:11:32 GMT Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation - accessnewswire.comaccessnewswire.com · Sun, 02 Aug 2026 22:56:40 GMT

Timeline

Sat, 08 Aug 2026 06:56:07 GMTALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Fri, 07 Aug 2026 16:36:05 GMTAldeyra Therapeutics Inc (ALDX) Stock News Today - TradingKey

Fri, 07 Aug 2026 14:27:03 GMTAldeyra Therapeutics Inc (ALDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Fri, 07 Aug 2026 02:14:15 GMTAldeyra Therapeutics (NASDAQ:ALDX) Announces Quarterly Earnings Results - MarketBeat

Thu, 06 Aug 2026 21:37:49 GMTAldeyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 20:11:01 GMTAldeyra Therapeutics, Inc. Q2 2026: Net loss $5.45M, EPS $(0.09) — 10-Q Summary - TradingView

Related explainers

PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

ALDX14 live mentions Inc11 live mentions Gewirtz6 live mentions Grossman6 live mentions Bronstein5 live mentions NASDAQ4 live mentions Concord4 live mentions The National Law3 live mentions Aldeyra Therapeutics Inc3 live mentions Therapeutics3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Aldeyra Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.